【24h】

Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients.

机译:乳腺管状癌:307例患者的结局和局部复发。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: The aim of this study is to describe the University of Florence experience in evaluating clinical, pathologic and treatment factors as they are related to the outcome and loco-regional recurrence in patients with tubular breast carcinoma. MATERIAL AND METHODS: Three hundred and seven patients (median age 56.4 years, range 26-91 years) with histological verified tubular carcinoma of the breast were consecutively treated at University of Florence from 1976 to 2001. All patients were followed for a median of 8.4 years (range 3 months to 20 years). Thirty-seven women underwent mastectomy and 270 underwent breast conserving surgery. Positive axillary nodes were found in 15% of patients. Fifty-two patients did not undergo radiotherapy to whole breast after having breast conserving surgery. Tamoxifen was prescribed in 108 patients and chemotherapy in 21 patients, 15 out of 21 had positive axillary nodes. RESULTS: Cause specific survival was 99.6, 99.2 and 97.2% at 3, 5 and 10 years. Local recurrence rate was 1.9, 3.6 and 4.7% at 3, 5 and 10 years. Univariate statistical analysis was significant for specific survival and local recurrence for angiolymphatic invasion only (p=0.0004). CONCLUSIONS: In the absence of axillary disease and angiolymphatic invasion, conserving surgery with adjuvant radiotherapy is effective treatment of disease.
机译:目的:本研究的目的是描述佛罗伦萨大学在评估临床,病理和治疗因素方面的经验,因为它们与肾小管癌患者的结局和局部复发有关。材料与方法:1976年至2001年,在佛罗伦萨大学连续治疗了307例经组织学检查证实为乳腺小管癌的患者(中位年龄56.4岁,范围26-91岁)。所有患者的中位数为8.4年(范围为3个月至20年)。三十七名妇女接受了乳房切除术,其中270名接受了保留乳房的手术。 15%的患者发现腋窝淋巴结阳性。 52例保乳手术后未对整个乳房进行放射治疗。 108例患者接受他莫昔芬治疗,21例患者接受化疗,其中21例中有15例腋窝淋巴结阳性。结果:在3、5和10年时,病因特异性存活率分别为99.6、99.2和97.2%。在3、5和10年时,局部复发率分别为1.9、3.6和4.7%。单因素统计分析仅对血管淋巴管浸润的特定生存率和局部复发有意义(p = 0.0004)。结论:在没有腋窝疾病和血管淋巴管浸润的情况下,采用辅助放疗的保守手术是有效的疾病治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号